These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 38448612)

  • 21. Plasma levels of soluble urokinase plasminogen activator receptor (suPAR) and high-sensitivity C-reactive protein after Roux-en-Y gastric bypass or sleeve gastrectomy: a 1-year prospective observational study.
    Kokkinos A; Liaskos C; Alexiadou K; Papassotiriou I; Margeli A; Argyrakopoulou G; Perrea D; Alexandrou A; Katsilambros N; Diamantis T; Tentolouris N
    J Endocrinol Invest; 2021 Mar; 44(3):599-608. PubMed ID: 32681464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD.
    Gumus A; Altintas N; Cinarka H; Kirbas A; Hazıroglu M; Karatas M; Sahin U
    Int J Chron Obstruct Pulmon Dis; 2015; 10():357-65. PubMed ID: 25709430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation.
    Rasmussen LJH; Petersen JEV; Eugen-Olsen J
    Front Immunol; 2021; 12():780641. PubMed ID: 34925360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum Levels of Soluble Urokinase Plasminogen Activator Receptor in Infants with Late-onset Sepsis.
    Okulu E; Arsan S; Akin IM; Ates C; Alan S; Kilic A; Atasay B
    J Clin Lab Anal; 2015 Sep; 29(5):347-52. PubMed ID: 25043869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble urokinase-type plasminogen activator receptor levels in patients with burn injuries and inhalation trauma requiring mechanical ventilation: an observational cohort study.
    Backes Y; van der Sluijs KF; Tuip de Boer AM; Hofstra JJ; Vlaar AP; Determann RM; Knape P; Mackie DP; Schultz MJ
    Crit Care; 2011; 15(6):R270. PubMed ID: 22085408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble urokinase plasminogen activator receptor is linearly associated with dietary quality and predicts mortality.
    Törnkvist PBS; Haupt TH; Rasmussen LJH; Ladelund S; Toft U; Pisinger C; Eugen-Olsen J
    Br J Nutr; 2019 Mar; 121(6):699-708. PubMed ID: 30626457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diagnostic value of soluble urokinase plasminogen activator receptor compared with C-reactive protein and procalcitonin in children with febrile neutropenia.
    Sirinoglu M; Soysal A; Karaaslan A; Kepenekli Kadayifci E; Cinel I; Koç A; Tokuç G; Yaman A; Haklar G; Şirikçi Ö; Turan S; Altınkanat Gelmez G; Söyletir G; Bakır M
    Pediatr Hematol Oncol; 2016 Apr; 33(3):200-8. PubMed ID: 27057782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of soluble urokinase plasminogen activator receptor, soluble triggering receptor expressed on myeloid cells 1, procalcitonin and C-reactive protein in distinguishing concurrent bacterial infection from idiopathic inflammatory myopathy.
    Xiao Y; Luo H; Zhou B; Dai X; Huang J; Duan L; You Y; Zhang W; Zhao H; Xie Y; Zhou Y; Ning W; Li T; Liu S; Zhu H; Xie X; Jiang Y; Wu S; He W; Li Y
    Rheumatol Int; 2017 Apr; 37(4):585-592. PubMed ID: 27878344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The predictive value of soluble urokinase plasminogen activator receptor (SuPAR) regarding 90-day mortality and 12-month neurological outcome in critically ill patients after out-of-hospital cardiac arrest. Data from the prospective FINNRESUSCI study.
    Jalkanen V; Vaahersalo J; Pettilä V; Kurola J; Varpula T; Tiainen M; Huhtala H; Alaspää A; Hovilehto S; Kiviniemi O; Kuitunen A; Tenhunen J;
    Resuscitation; 2014 Nov; 85(11):1562-7. PubMed ID: 25193800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cadmium exposure is associated with soluble urokinase plasminogen activator receptor, a circulating marker of inflammation and future cardiovascular disease.
    Fagerberg B; Borné Y; Barregard L; Sallsten G; Forsgard N; Hedblad B; Persson M; Engström G
    Environ Res; 2017 Jan; 152():185-191. PubMed ID: 27792942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pro-inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) is associated with incident type 2 diabetes among overweight but not obese individuals with impaired glucose regulation: effect modification by smoking and body weight status.
    Heraclides A; Jensen TM; Rasmussen SS; Eugen-Olsen J; Haugaard SB; Borch-Johnsen K; Sandbæk A; Lauritzen T; Witte DR
    Diabetologia; 2013 Jul; 56(7):1542-6. PubMed ID: 23613086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia.
    Genc A; Kalelioglu T; Karamustafalioglu N; Tasdemir A; Genc ES; Akkus M; Emul M
    Psychiatry Res; 2016 Feb; 236():179-181. PubMed ID: 26774189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations between soluble urokinase plasminogen activator receptor (suPAR) concentration and psychiatric disorders - A systematic review and meta-analysis.
    Murphy J; Zierotin A; Mongan D; Healy C; Susai SR; O'Donoghue B; Clarke M; O'Connor K; Cannon M; Cotter DR
    Brain Behav Immun; 2024 Aug; 120():327-338. PubMed ID: 38857636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGS.
    Li F; Zheng C; Zhong Y; Zeng C; Xu F; Yin R; Jiang Q; Zhou M; Liu Z
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1903-11. PubMed ID: 25318750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum levels of the soluble urokinase plasminogen activator receptor (suPAR) correlates with disease activity in early rheumatoid arthritis and reflects joint damage over time.
    Enocsson H; Lukic T; Ziegelasch M; Kastbom A
    Transl Res; 2021 Jun; 232():142-149. PubMed ID: 33582243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD.
    Luo S; Coresh J; Tin A; Rebholz CM; Chen TK; Hayek SS; Tracy M; Lipkowitz MS; Appel LJ; Levey AS; Inker LA; Reiser J; Grams ME
    Clin J Am Soc Nephrol; 2018 Jul; 13(7):1013-1021. PubMed ID: 29903900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urokinase plasminogen activator receptor and soluble matrix metalloproteinase-9 in acute myeloid leukemia patients: a possible relation to disease invasion.
    Aref S; El-Sherbiny M; Mabed M; Menessy A; El-Refaei M
    Hematology; 2003 Dec; 8(6):385-91. PubMed ID: 14668033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men.
    Haugaard SB; Andersen O; Hansen TW; Eugen-Olsen J; Linneberg A; Madsbad S; Olsen MH; Jørgensen T; Borch-Johnsen K; Jeppesen J
    Diabet Med; 2012 Apr; 29(4):479-87. PubMed ID: 22050462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative Levels of the Soluble Urokinase-Type Plasminogen Activator Receptor as Predictor for New Episodes of Atrial Fibrillation After Vascular Surgery.
    Lazarević M; Golubović M; Milić D; Stanojević D; Kostić T; Đorđević M; Marjanović V; Perić V
    Vasc Endovascular Surg; 2021 Jul; 55(5):461-466. PubMed ID: 33622185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The significance of serum urokinase plasminogen activation receptor (suPAR) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies.
    Kaya S; Köksal I; Menteşe A; Sönmez M; Sümer A; Yıldırım SS; Yılmaz G
    Int J Infect Dis; 2013 Nov; 17(11):e1056-9. PubMed ID: 23742830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.